In 2003, Dana-Farber mapped out a research strategic plan to promote the clinical application of our understanding about the molecular characteristics of cancer while furthering work that generates that fundamental knowledge.
The creation of cross-cutting integrative research centers addresses the steps from basic discovery to clinical application, complementing the scientific work accomplished through academic departments.
The integrative research centers participate in a rigorous process of goal setting, progress monitoring, and performance metrics. They are an Institute-wide experiment to see if this kind of results-driven strategy can be successful alongside traditional, open-ended, investigator-driven research.
Blais Proteomics Center
Cancer Vaccine Center
Center for Biomedical Imaging in Oncology
Center for Cancer Computational Biology
Center for Cancer Genome Discovery
Center for Cancer Systems Biology
Center for Clinical and Translational Research
Center for DNA Damage and Repair
Center for Functional Cancer Epigenetics
Chemical Biology Initiative
Dana-Farber/Brigham and Women's Center for Molecular Oncologic Pathology
McGraw/Patterson Center for Population Sciences
Perini Family Survivors' Center
Robert and Renée Belfer Center for Applied Cancer Science